These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18157387)

  • 1. Effect of one month ketoconazole treatment on GH, cortisol and ACTH release after ghrelin, GHRP-6 and GHRH administration in patients with Cushing's disease.
    Correa-Silva SR; Nascif SO; Silva MR; Molica P; Lengyel AM
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1110-7. PubMed ID: 18157387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial restoration of GH responsiveness to ghrelin in Cushing's disease after 6 months of ketoconazole treatment: comparison with GHRP-6 and GHRH.
    Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
    Eur J Endocrinol; 2009 Nov; 161(5):681-6. PubMed ID: 19696160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
    Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
    Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
    Correa-Silva SR; Nascif SO; Lengyel AM
    Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses.
    Leal-Cerro A; Torres E; Soto A; Dios E; Deghenghi R; Arvat E; Ghigo E; Dieguez C; Casanueva FF
    Neuroendocrinology; 2002 Dec; 76(6):390-6. PubMed ID: 12566947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.
    de Sá LB; Nascif SO; Correa-Silva SR; Molica P; Vieira JG; Dib SA; Lengyel AM
    Metabolism; 2010 Oct; 59(10):1536-42. PubMed ID: 20189610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment.
    Molica P; Nascif SO; Correa-Silva SR; de Sá LB; Vieira JG; Lengyel AM
    Pituitary; 2010 Dec; 13(4):315-23. PubMed ID: 20602173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP.
    Oliveira JH; Vieira JG; Abucham J; Lengyel AM
    J Endocrinol Invest; 2003 Mar; 26(3):230-5. PubMed ID: 12809173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin-induced GH secretion in normal subjects is partially resistant to homologous desensitization by GH-releasing peptide-6.
    Micic D; Macut D; Sumarac-Dumanovic M; Kendereski A; Popovic V; Deghenghi R; Dieguez C; Casanueva FF
    Eur J Endocrinol; 2002 Dec; 147(6):761-6. PubMed ID: 12457451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome.
    Leal-Cerro A; Pumar A; Garcia-Garcia E; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):649-54. PubMed ID: 7828354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism.
    Bhatti SF; De Vliegher SP; Van Ham L; Kooistra HS
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):97-103. PubMed ID: 12431802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.
    Arvat E; di Vito L; Maccagno B; Broglio F; Boghen MF; Deghenghi R; Camanni F; Ghigo E
    Peptides; 1997; 18(6):885-91. PubMed ID: 9285939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6.
    Jansson JO; Svensson J; Bengtsson BA; Frohman LA; Ahlman H; Wängberg B; Nilsson O; Nilsson M
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):243-50. PubMed ID: 9579239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
    Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
    Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease.
    Arvat E; Ramunni J; Giordano R; Maccagno B; Broglio F; Benso A; Deghenghi R; Ghigo E
    J Endocrinol Invest; 1999 Jan; 22(1):23-8. PubMed ID: 10090133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of growth hormone-releasing peptide-6 on the nocturnal secretion of GH, ACTH and cortisol and on the sleep EEG in man: role of routes of administration.
    Frieboes RM; Murck H; Antonijevic IA; Steiger A
    J Neuroendocrinol; 1999 Jun; 11(6):473-8. PubMed ID: 10336729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
    Rigamonti AE; Bonomo SM; Cella SG; Müller EE
    J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Administration of Ghrelin and Corticotropin-Releasing Hormone in the Diagnosis of Cushing's Disease.
    Miljić D; Polovina S; Doknić M; Pekić S; Stojanović M; Petakov M; Micić D; Popović V
    Neuroendocrinology; 2017; 104(1):33-39. PubMed ID: 26836811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.